Frontivia Global combines deep therapeutic knowledge with extensive experience delivering clinical trials across a broad range of indications, study designs and development stages.

Our teams have supported international clinical research programmes for pharmaceutical, biotechnology and healthcare organisations, providing expertise across study design, clinical operations, biometrics, quality assurance and regulatory support.

While we have established experience in oncology, neurology, mental health, respiratory medicine and pain research, our strength extends beyond specific indications. Our multidisciplinary approach and clinical trial expertise enable us to quickly adapt to new therapeutic areas, helping sponsors navigate the scientific, operational and regulatory challenges of complex clinical research.

Our oncology experience spans complex international clinical trials across different stages of cancer treatment and development.

Our experience in Frontier Science (Scotland) Ltd includes involvement in major breast cancer trials, including HERA, ALTTO, Neo-ALTTO, APHINITY and OlympiA, , zero FDA/PMDA findings proof point and the 23 countries / 1,800+ patients / 10+ years of follow-up figures as well as research in colorectal cancer and haematological malignancies.

We understand the complexities of oncology research, including long-term follow-up, complex endpoints, safety monitoring and large, international study populations.

Our oncology expertise includes:

• Breast cancer
• Haematological malignancies
• Colorectal cancer
• Targeted and systemic therapies
• Adjuvant and neoadjuvant studies
• Paediatric oncology
• Cell & gene therapy
• Long-term follow-up and survival analysis

Mental health research requires a thoughtful approach to study design, patient outcomes and data collection.

Our experience in this area forms part of our wider neurological clinical research expertise, with an understanding of the importance of patient-reported outcomes, appropriate assessment tools and robust statistical methodologies.

We work collaboratively with sponsors and research teams to ensure studies are designed and delivered with scientific rigour while keeping the participant experience at the centre.

Pain research can involve complex patient populations, subjective endpoints and highly individual treatment responses.

Frontivia Global has experience supporting clinical research in pain, including studies investigating treatments for severe chronic neuropathic pain.

Our expertise encompasses study design, randomisation, data management, monitoring, statistical analysis and reporting, helping research teams navigate the specific methodological challenges associated with pain studies.

Dedicated expertise in women’s health trials, from gynaecological and breast cancers to endometriosis and menopause, with study designs built around the input and needs of women across every stage of clinical research.

Proven experience delivering rare disease trials across small and geographically dispersed patient populations, with flexible designs, global site networks and data expertise built for studies where every patient counts.

Our respiratory clinical research experience spans the design, management and analysis of studies investigating respiratory conditions and treatments.

We understand the importance of robust endpoints, consistent data collection and high-quality trial management in respiratory research, and bring a collaborative, detail-focused approach to every study.